Skin Cancer and Melanoma Clinical Trials

Skin Cancer and Melanoma Clinical Trials

  • 07.0008 - Adjuvant Interleukin 2 (Proleukin) and 5-(3,3-Dimethyl-1-Triazeno)Imidazole-4-Carboxamide (DTIC) In Resected High-Risk Primary and Regionally Metastatic Melanoma  learn more
  • 08.0127 - Open-label pharmacokinetic trial of aldesleukin (rh-interleukin-2 [IL-2]) administered intravenously to subjects with metastatic renal cell carcinoma or metastatic melanoma with immunologic correlative studies   learn more
  • 08.0243 - Phase II Trial of Transient T Cell Depletion With Cyclophosphamide In Stage IV Melanoma  learn more
  • 09.0087 - A Randomized Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Treatment with OncoVEXGM-CSF Compared to Subcutaneously Administered GM-CSF in Previously Treated Melanoma Patients with Unresectable Stage IIIb, IIIc and IV Disease  learn more
  • 08.0316 - A Follow-up Study of Breast Cancer and Melanoma Patients that Participated in the Phase 2 Clnical Study NEO3-01 for Lymphoseek  learn more
  • 04.0462 - A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection vs. Sentinel Lymphadencetomy Alone in Cutaneous Melanoma Subjects with Molecular or Histopathological Evidence of Metastases in the Sentinel Node  learn more